AI-generated summary
The authors describe four patients with striae distensae that developed after long-term topical corticosteroid use and were treated with a fractional nonablative 1540 nm erbium glass laser. They report the treatment was successful in these patients. The report describes only a small number of cases and no comparison group is mentioned.
- Participants
- 4
- Who or what was studied
- Four patients with Fitzpatrick phototype IV who developed striae distensae after long-term use of topical corticosteroids
- Wavelengths
- 1540 nm
- Limits stated in the abstract
- Case description of only four patients with no control group, so the findings cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1540nm, 1540 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.